Jun 18, 2021 10:29 AM IST
Novavax has announced promising results from its COVID-19 vaccine candidate’s phase-3 clinical trials in the United States and Mexico
- Jun 17, 2021 08:33 AM IST
Novavax's COVID-19 vaccine has demonstrated 93 percent effectiveness against novel coronavirus' variants of concern and variants of interest.
- Jun 16, 2021 10:06 AM IST
In September 2020, Novavax had announced a manufacturing agreement with the Serum Institute of India for its COVID-19 vaccine candidate NVX-CoV2373.
- Jun 14, 2021 03:38 PM IST
Novavax's COVID-19 vaccine demonstrated 93 percent effectiveness against novel coronavirus' variants of concern and variants of interest.
- May 13, 2021 05:54 PM IST
The move by Uttar Pradesh, home to more people than Brazil, comes as many Indian states curtail vaccinations due to severe shortages amid a record surge in coronavirus infections, with India recording more than 4,000 deaths for a second straight day as its health system fails to cope.
- May 04, 2021 03:45 PM IST
The ICMR and SII are jointly performing a phase-2/3 observer-blind, randomised, controlled study to determine the safety and efficacy of the Covovax vaccine.
- Apr 06, 2021 09:42 PM IST
If NDV-HXP-S proves safe and effective, flu vaccine manufacturers could potentially produce well over a billion doses of it a year. Low- and middle-income countries currently struggling to obtain vaccines from wealthier countries may be able to make NDV-HXP-S for themselves or acquire it at low cost from neighbors.
- Apr 06, 2021 03:39 PM IST
Allowing volunteers to crossover to the active vaccine offers them an incentive to continue in the trials even when other authorized vaccines are available.
- Feb 18, 2021 04:53 PM IST
Though the revised presidential rule has made strict provisions for those who refuse the vaccine by stopping or delaying social assistance programs, the administration has left the final decision of the final sanction to local governments to decide.
- Jan 29, 2021 07:55 AM IST
The announcement comes amid worry about whether a variety of vaccines being rolled out will be strong enough to protect against new variants – and as the world desperately needs new types of shots to boost scarce supplies.
- Jan 20, 2021 08:44 PM IST
In the initial phase, India will inoculate about one crore healthcare workers. This will be followed by two crore frontline workers, police, armed forces, municipal workers, revenue staff and others. In the third phase, 27 crore people above 50 years of age and those with co-morbidities.
- Dec 02, 2020 05:45 PM IST
India's COVID-19 vaccination drive will be among the largest in the world and is likely to happen in phases.
- Nov 30, 2020 06:15 PM IST
It is the second time that Novavax, which already has a late-stage UK trial underway, has rescheduled the Phase 3 trial after first flagging an October start, hampered by issues in scaling up its manufacturing.
- Sep 15, 2020 03:14 PM IST
Novavax's vaccine is currently in mid-stage trials after an early-stage study showed it produced high levels of antibodies against the novel coronavirus. The company plans to begin late-stage trials in the third quarter.
- Aug 17, 2020 02:05 PM IST
The Phase 2b trial study of NVX-CoV2373 will be conducted on about 2,665 healthy adults and will evaluate the safety and immunogenicity in about 240 medically stable, HIV-positive adults, the company said in a statement.
- May 26, 2020 11:29 AM IST
The Maryland-based late-stage biotechnology company in April said it identified the candidate, NVX-CoV2373, with which it planned to use its Matrix-M adjuvant to enhance immune responses.